XML 90 R79.htm IDEA: XBRL DOCUMENT v3.21.1
COMMITMENTS AND CONTINGENCIES - Narrative (Details)
3 Months Ended
Jul. 29, 2019
USD ($)
Mar. 31, 2021
USD ($)
liability
Dec. 31, 2020
USD ($)
Mar. 31, 2020
USD ($)
Accrued Liabilities        
Loss Contingencies [Line Items]        
Contingent consideration   $ 3,400,000    
Other liabilities        
Loss Contingencies [Line Items]        
Contingent consideration   12,000,000 $ 13,200,000  
Arkis        
Loss Contingencies [Line Items]        
Purchase price of business combination $ 30,600,000      
Contingent consideration, estimated fair value 25,500,000      
Contingent consideration 13,100,000 $ 15,400,000   $ 13,200,000
Arkis | Development Milestones        
Loss Contingencies [Line Items]        
Contingent consideration, estimated fair value 10,000,000.0      
Arkis | Commercial Sales Milestones        
Loss Contingencies [Line Items]        
Contingent consideration, estimated fair value $ 15,500,000      
Derma Sciences        
Loss Contingencies [Line Items]        
Contingent consideration, estimated fair value       $ 200,000
Number of contingent liabilities remaining | liability   1    
Contingent consideration, maximum undiscounted payment amount   $ 3,000,000.0    
Derma Sciences | BioD Earnout Payments and Medihoney Earnout Payments        
Loss Contingencies [Line Items]        
Payment for contingent consideration   $ 33,300,000